CLINICAL_TRIALS
trial_result
· 2024-01-23
Clinical Trial Update: Soy Protein and Breast Cancer Risk Reduction [Phase 2]
Summary
Phase 2 clinical trial update investigating soy protein for breast cancer risk reduction has been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: The University of Texas Medical Branch, Galveston | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-01-23